Wuxi XDC IPO Reinvigorates Health Care Sector, Week In Review
Pharmaceutical contract research organization Wuxi XDC gained +36% in its stock market debut in Hong Kong overnight.
Disclaimer : We make no assurance about the completeness and accuracy of the content of this website. All news on this website is collected from various sources hence information may or may not be true. Money Nations does not verify the reliability of the content published. We do not accept any accountability for loss or damage occurred as a result of reliability on the content of this website.